125459 -

: Evaluating whether the viral vector or therapeutic gene could unintentionally be passed on to future generations.

: Defining scientific principles for non-clinical studies specifically for gene therapies, which differ significantly from conventional pharmaceuticals. Key Safety Requirements : 125459

This document outlines the essential safety and efficacy data that developers must generate during the "non-clinical" (animal or lab) phase to justify moving into human subjects. : Evaluating whether the viral vector or therapeutic

Guideline on the Non-Clinical Studies Required before First ... - EMA Guideline on the Non-Clinical Studies Required before First

: Characterizing potential immune responses to the viral vector or the new protein produced by the therapy.

For more detailed technical specifications, you can access the full Guideline on Non-Clinical Studies for GTMPs via the official .

The number most commonly refers to a specific scientific guideline established by the European Medicines Agency (EMA) regarding the development of Gene Therapy Medicinal Products (GTMPs) .